Noncolorectal Gastrointestinal Cancer News

• Experts Question Antitrust Arguments Against Illumina-Grail Deal US and European antitrust enforcers want to unwind gene sequencing leader Illumina Inc's purchase of cancer test company Grail, saying the two would stifle competition in a critical area of medicine.
  Reuters Health Information, December 16, 2022
• Post-op Chemo Has Limited Benefit in Some Esophageal Cancers Patients with stage IIA and IIB esophageal squamous cell carcinoma with lymphovascular invasion but negative lymph nodes do not benefit. The study was published as a preprint and has not yet been peer reviewed.
  First Look, December 16, 2022
• Oncologists Overwhelmed; Cluster Headaches; and Liver Cancer Cost The top 3 things you should know to start your day.
  3 Things to Know Today, December 16, 2022
• Liver Cancer Exacts High Financial Toll on Older Adults The financial burden of hepatocellular carcinoma, the most common type of liver cancer, is high for Medicare beneficiaries in the first year after diagnosis.
  Medscape Medical News, December 15, 2022
• SABCS 2022 Chemotherapy Meets Its Match Against Aggressive ER+/HER2– BRCAs In the phase 2 RIGHT Choice study, first-line ribociclib, combined with either letrozole or anastrozole plus goserelin, was associated with a doubling of progression-free survival.
  MDedge News, December 13, 2022
• SABCS 2022 Oral SERD Camizestrant Prolongs PFS vs Fulvestrant in Breast Cancer "The results of SERENA-2 support further development of camizestrant in ER-positive breast cancer."
  MDedge News, December 13, 2022
• How Fitness Trackers Will Help Us Keep an Eye on Disease A new study suggests that Fitbit data — including heart rate and step count — could serve as a proxy for important clinical metrics, providing key insights to help treat chronic disease.
  WebMD, December 13, 2022
• AASLD 2022 A Bold National Plan to Eliminate HCV by 2050 If implemented as proposed by three preeminent scientists, the ambitious program would save many thousands of lives, and nearly $60 billion in future healthcare costs.
  Medscape Medical News, December 09, 2022
• Japanese Biotech Firm Uses Tiny Worms in Test for Pancreatic Cancer A Japanese biotech firm says it has developed the world's first early screening test for pancreatic cancer, using the powerful noses of tiny worms.
  Reuters Health Information, November 30, 2022
• AASLD 2022 Poor NAFLD Outcomes With Increased VCTE-Measured Liver Stiffness A prospective cohort study showed that patients with progression to cirrhosis measured by vibration-controlled transient elastography had a nearly twofold greater risk for poor outcomes or death.
  Medscape Medical News, November 21, 2022
• Atezolizumab Fails to Improve Outcomes in Postsurgery Kidney Cancer "Our results add to an emerging body of literature around the role of adjuvant immunotherapy for renal cell carcinoma. With the longest duration of follow-up to date to our knowledge."
  MDedge News, November 18, 2022
• Neoadjuvant Therapy Improves Survival in Metastatic Colon Cancer Among patients with metastatic colon cancer with liver or lung lesions who received neoadjuvant therapy, survival was longer in comparison with patients who received adjuvant therapy, but only in nonacademic settings.
  Medscape Medical News, November 18, 2022
• FDA Warning Letter Cites Abraxane Manufacturing Sterility Issues The warning follows an FDA inspection at the Phoenix-based Abraxis BioScience plant that found contamination hazards in its manufacturing process.
  Medscape Medical News, November 15, 2022
• The Changes Made in the New Expert Consensus on H pylori With the last update published in 2017, current consensus, released in August 2022, covers most of the latest progress made in the management of the infection.
  Medscape Medical News, November 15, 2022
• NAFLD Patients With Diabetes Have Higher Fibrosis Progression Rate Progression rates for people with NAFLD and diabetes were higher than those without diabetes, researchers found.
  MDedge News, November 12, 2022
• Chronic HBV Infections Associated With Liver Malignancies Treatment with nucleos(t)ide analogues lowers risk of extrahepatic cancer in patients with hepatitis B infections.
  MDedge News, November 12, 2022
• Cancer Death Rates High in American Indians and Alaska Natives Cancer mortality rates among American Indian and Alaska Native patients are higher than for White patients despite similar rates of cancer incidence overall.
  Medscape Medical News, November 10, 2022
• AASLD 2022 Higher Fibrosis Progression Rate in NAFLD Patients With Diabetes Patients with type 2 diabetes had about a 2-year faster progression to fibrosis.
  MDedge News, November 09, 2022
• How a Wrong Diagnosis Masked a Young Woman's Cancer A genetic disorder called Lynch syndrome provided a clue that Ashley Teague's black, tar-like stools and diarrhea were more serious than IBS. It took a frustratingly long 7 months to solve the mystery.
  WebMD Health News, November 08, 2022
• Pfizer's COVID Cash Powers the Hunt for Supernovas While sales of its COVID vaccines are falling, Pfizer plans to triple the price of the shots and use its bonanza from government contracts to buy and develop new blockbusters.
  Kaiser Health News, November 08, 2022